Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.51 |
| ▸ | CDK1 | P06493 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 3/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | GLA | P06280 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | USP2 | O75604 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 2/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | P2RY1 | P47900 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3500776 | 0.85 | GAA (0.48) | GAACDK1CYP1A2MAPTTP53 | |
| SCHEMBL8535700 | 0.85 | GAA (0.52) | GAACDK1CYP1A2MAPTTP53 | |
| SCHEMBL55236 | 0.85 | GAA (0.52) | GAACDK1CYP1A2MAPTTP53 | |
| SCHEMBL1024744 | 0.80 | GAA (0.47) | GAACDK1CYP1A2MAPTTP53 | |
| SCHEMBL734690 | 0.80 | GAA (0.51) | GAACDK1CYP1A2MAPTTP53 | |
| SCHEMBL9362781 | 0.80 | GAA (0.46) | GAACDK1MAPTTP53GLA | |
| SCHEMBL9367810 | 0.80 | GAA (0.53) | GAACDK1CYP1A2MAPTTP53 | |
| SCHEMBL12633039 | 0.79 | GAA (0.46) | GAACDK1MAPTTP53GLA | |
| SCHEMBL9357219 | 0.78 | GAA (0.48) | GAACDK1CYP1A2MAPTTP53 | |
| SCHEMBL9517338 | 0.78 | GAA (0.50) | GAACDK1CYP1A2KDM4EHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8476021-B2 | — | — | 2013-07-02 | — | — | US | disclosed |
| US-20100184079-A1 | SOYBEAN EVENT 3560.4.3.5 AND COMPOSITIONS AND METHODS FOR THE IDENTIFICATION AND DETECTION THEREOF | PIONEER HI-BRED INTERNATIONAL, INC. (US) | 2010-07-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100184079-A1 | SOYBEAN EVENT 3560.4.3.5 AND COMPOSITIONS AND METHODS FOR THE IDENTIFICATION AND DETECTION THEREOF | GMNN, DDX20, DPY30 | GAA 900/4885CDK1 794/4885CYP1A2 3269/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.